BD PharmingenTM PE-CyTM7 Mouse Anti-Human HLA-DR

Description

Flow cytometric analysis of HLA-DR on human peripheral lymphocytes. Human whole blood was stained with the PE-Cy7 Mouse Anti-Human HLA-DR antibody Cat. No. 560651; open histogram or with a PE-Cy7 Mouse IgG2a, kappa isotype control Cat. No. 557907; filled histogram . Erythrocytes were lysed with BD FACS Lysing Solution Cat. No. 349202 . Histograms were derived from gated events based on light scattering characteristics for lymphocytes. Flow cytometry was performed on a BD LSR II flow cytometry system. Flow cytometric analysis of HLA-DR on human peripheral lymphocytes. Human whole blood was stained with the PE-Cy7 Mouse Anti-Human HLA-DR antibody Cat. No. 560651; open histogram or with a PE-Cy7 Mouse IgG2a, kappa isotype control Cat. No. 557907; filled histogram . Erythrocytes were lysed with BD FACS Lysing Solution Cat. No. 349202 . Histograms were derived from gated events based on light scattering characteristics for lymphocytes. Flow cytometry was performed on a BD LSR II flow cytometry system. Show More Flow cytometric analysis of HLA-DR on human peripheral lymphocytes. Human whole blood was stained with the PE-Cy7 Mouse Anti-Human HLA-DR antibody Cat. No. 560651; open histogram or with a PE-Cy7 Mouse IgG2a, kappa isotype control Cat. No. 557907; filled histogram . Erythrocytes were lysed with BD FACS Lysing Solution Cat. No. 349202 . Histograms were derived from gated events based on light scattering characteristics for lymphocytes. Flow cytometry was performed on a BD LSR II flow cytometry system.